Form 4: Hinge Health CFO Plans Future Gift of 20,000 Shares

Sentiment:

Insider Transaction Report


Hinge Health's Chief Financial Officer, James Budge, reported a pre-planned gift of 20,000 Class A Common Stock shares.

Summary

  • James Budge, Chief Financial Officer of Hinge Health, Inc., reported a planned disposition of 20,000 shares of Class A Common Stock.
  • The transaction, identified as a gift (Transaction Code 'G'), is scheduled for December 11, 2025.
  • The shares are to be disposed of at a price of $0.
  • Following this planned transaction, James Budge will directly beneficially own 451,665 shares of Class A Common Stock.
  • This disposition is being made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.

Sentiment

Score: 5

Explanation: The CFO reported a pre-planned gift of 20,000 shares scheduled for a future date (December 11, 2025) under a Rule 10b5-1 plan. While it reduces direct insider ownership, it is not a sale for cash and was pre-arranged, making it a neutral event for immediate stock performance.

Negatives

  • A planned reduction in direct insider ownership by a key executive, though a gift and not a sale for cash.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Industry Context

Not directly applicable as this filing reports an individual insider transaction, not broader industry trends or competitive dynamics.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership by a key executive is reported. This is generally a neutral to slightly negative signal, as it reduces the executive's direct financial alignment with shareholders, though it is a gift and not a sale for cash.

Key Dates

DateDescription
12/11/2025Scheduled date of transaction where 20,000 shares are to be gifted.
12/12/2025Date the Form 4 was signed and filed.

Recommendation

hold

The filing reports a routine insider gift of shares by the CFO under a pre-arranged 10b5-1 plan, scheduled for a future date. This type of transaction is generally not considered a strong signal for stock performance and does not provide sufficient information to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Hinge Health, HNGE, James Budge, CFO, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, Class A Common Stock, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.